VolitionRx reduces authorized common shares from 325M to 150M after stockholder vote

VOLITIONRX LTD

Authorized common shares cut from 325M to 150M via Certificate of Fourth Amendment filed July 17, 2026.
Stockholders approved the amendment with 4,011,189 votes for, 218,947 against at 2026 annual meeting.
All seven director nominees elected; Sadler, Gibb ratified as auditor for FY2026.
2026 Stock Incentive Plan approved by stockholders (2,078,833 for, 182,048 against).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.